Price J A, McGee J M, Patten M R, Snyder D
Department of Biochemistry and Microbiology, College of Osteopathic Medicine, Oklahoma State University, Tulsa 74107, USA.
Int J Immunopharmacol. 1996 Feb;18(2):163-5. doi: 10.1016/0192-0561(96)00003-3.
Mice were injected three times at 2 week intervals with the adjuvant MPL + TDM or phosphate-buffered saline. Two weeks after the last injection, all mice were challenged subcutaneously with a tumorgenic dose of B16 tumor and observed for 40 days. The adjuvant hastened the time at which tumors appeared (P = 0.02).
每隔2周给小鼠注射3次佐剂MPL + TDM或磷酸盐缓冲盐水。最后一次注射后2周,所有小鼠皮下注射致瘤剂量的B16肿瘤并观察40天。该佐剂缩短了肿瘤出现的时间(P = 0.02)。